These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25241757)

  • 1. Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?
    Eker SS; Yavasci EO; Cangur S; Kirli S; Sarandol E
    Acta Neuropsychiatr; 2014 Oct; 26(5):291-7. PubMed ID: 25241757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of biomarkers and depressive symptoms in schizophrenia.
    Noto CS; Gadelha A; Belangero SI; Smith MA; de Aguiar BW; Panizzuti B; Mari Jde J; Gama CS; Bressan RA; Brietzke E
    Neurosci Lett; 2011 Nov; 505(3):282-5. PubMed ID: 22044873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia.
    Wysokiński A
    Nord J Psychiatry; 2016; 70(4):267-71. PubMed ID: 26548545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of last depressive episode may influence serum BDNF levels in remitted patients with major depression.
    Takebayashi N; Maeshima H; Baba H; Nakano Y; Satomura E; Kita Y; Namekawa Y; Nomoto H; Suzuki T; Arai H
    Depress Anxiety; 2012 Sep; 29(9):775-9. PubMed ID: 22447660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased levels of brain-derived neurotrophic factor in the remitted state of unipolar depressive disorder.
    Hasselbalch BJ; Knorr U; Bennike B; Hasselbalch SG; Søndergaard MH; Vedel Kessing L
    Acta Psychiatr Scand; 2012 Sep; 126(3):157-64. PubMed ID: 22292883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
    Reis HJ; Nicolato R; Barbosa IG; Teixeira do Prado PH; Romano-Silva MA; Teixeira AL
    Neurosci Lett; 2008 Jul; 439(2):157-9. PubMed ID: 18514407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum BDNF levels in depressed patients cannot be attributed to individual depressive symptoms or symptom cluster.
    Bus BA; Molendijk ML; Penninx BW; Buitelaar JK; Prickaerts J; Elzinga BM; Voshaar RC
    World J Biol Psychiatry; 2014 Sep; 15(7):561-9. PubMed ID: 24219804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum brain-derived neurotrophic factor levels in conversion disorder: Comparative study with depression.
    Deveci A; Aydemir O; Taskin O; Taneli F; Esen-Danaci A
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):571-3. PubMed ID: 17875039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls.
    Yoshimura R; Umene-Nakano W; Hoshuyama T; Ikenouchi-Sugita A; Hori H; Katsuki A; Hayashi K; Atake K; Nakamura J
    Hum Psychopharmacol; 2010 Nov; 25(7-8):566-9. PubMed ID: 21312291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
    Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between BDNF and oxidative stress in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder.
    Aydemir O; Deveci A; Taskin OE; Taneli F; Esen-Danaci A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1023-6. PubMed ID: 17433517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode.
    Karlović D; Serretti A; Jevtović S; Vrkić N; Serić V; Peleš AM
    J Psychiatr Res; 2013 Feb; 47(2):162-7. PubMed ID: 23102630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration.
    Xiong P; Zeng Y; Wu Q; Han Huang DX; Zainal H; Xu X; Wan J; Xu F; Lu J
    J Clin Psychiatry; 2014 Aug; 75(8):e794-801. PubMed ID: 25191916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher serum tropomyosin-related kinase B protein level in major depression.
    Hung YY; Lin CJ; Huang TL
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):610-2. PubMed ID: 20202475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Huang TL; Lee CT; Liu YL
    J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.
    Umene-Nakano W; Yoshimura R; Ikenouchi-Sugita A; Hori H; Hayashi K; Ueda N; Nakamura J
    Hum Psychopharmacol; 2009 Jul; 24(5):409-13. PubMed ID: 19548207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
    Schennach R; Obermeier M; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M; Möller HJ
    Psychopathology; 2012; 45(5):276-85. PubMed ID: 22796716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.